Wuxi Apptec (02359.HK) received a shareholding of 2.5122 million shares from FMR LLC.
On September 16, Gelonhui reported that according to the latest equity disclosure information from the Hong Kong Stock Exchange, on September 10, 2024, Wuxi Apptec (02359.HK) received FMR LLC's on-market shareholding at an average price of HK$32.8673 per share, increasing its shareholding by 2.5122 million shares, with a total investment of approximately HK$82.5692 million. After the shareholding, FMR LLC's latest number of shares held is 32,210,818 shares, and its shareholding ratio has increased from 7.67% to 8.32%.
Listed companies have carried out intensive buybacks this week! Wuxi Apptec has launched its third round of 'cancellation-style' buyback plan this year, with a maximum repurchase amount of 0.1 billion yuan. Here is a list of A-share repurchase names.
①This week, the A-share listed companies continue to buy back stocks. According to incomplete statistics from Caixin, 11 listed companies plan to repurchase up to 0.1 billion yuan (see table); ②wuxi apptec, following the completion of the first two repurchase plans on February 5 and May 22, announced another 1 billion yuan repurchase plan on Tuesday evening. After the repurchase is completed, all repurchased shares will be cancelled and the registered capital will be reduced.
Express News | JPMorgan Chase & Co. Decreases Short Position in H-Shares of WuXi AppTec to 0.97% on Sept 10 From 1.71% - HKEX
Hong Kong stocks unusual | Wuxi AppTec (02359) rose nearly 5% again, intending to spend 1 billion yuan to repurchase shares. Management said the short-term impact of the US law is controllable.
wuxi apptec (02359) rose by nearly 5%, as of the press time, rose by 4.66%, at 38.15 Hong Kong dollars, with a turnover of 0.156 billion Hong Kong dollars.
wuxi apptec spent 39.235 million yuan on September 12th to buy back 0.9852 million A-shares.
On September 12, 2024, wuxi apptec (02359.HK) announced that it will repurchase 0.9852 million shares of A-shares for a total of 39.235 million yuan, at a repurchase price ranging from 38.54 to 40.2 yuan per share.
Hong Kong stocks closed (09.12) | Hang Seng Index rose 0.77%, technology and pharmaceutical stocks rose, wuxi apptec (02359) led the blue chips.
Today, the three major stock indexes in Hong Kong collectively rose, with all of them rising more than 1% at one point during the trading session. At the close, the Hang Seng Index rose 0.77% or 131.68 points to 17,240.39 points, with a total daily turnover of 91.68 billion Hong Kong dollars.
[Brokerage Focus] CMB International believes that the current stock price of Wuxi AppTec (02359) reflects extremely pessimistic expectations for its US business and is bullish on valuation rebound.
Jinwu Caixin | Zhongyi Guoji released a research report stating that the US House of Representatives passed the "Biosecurity Act" on September 9, local time. At present, even if the bill is passed, it may only affect a small number of government-funded projects, and the US business of Wuxi Apptec (02359/603259CH) is expected to remain relatively stable. Based on the company's rapidly growing order backlog, the bank believes that the company's profitability is expected to recover. The bank's analysis shows that the current stock price may already reflect extremely pessimistic expectations for the US business and is bullish on valuation rebound. The bank pointed out that customer demand is expected to gradually improve. Wuxi Apptec sees positive signs of improvement in customer demand.
Hong Kong stock market fluctuations | CXO concept stocks continue to rise in early trading. The Biosecurity Law is still waiting for the Senate to vote. Citigroup said that the stock price of the Chinese pharmaceutical company has been undervalued.
CXO concept stocks continued to rise in the morning session. As of the time of writing, Wuxi Bio (02269) rose 4.6% to HK$11.82; Wuxi Apptec (02359) rose 4.51% to HK$35.95; Pharmaron (03759) rose 3.84% to HK$9.73; Asymchem Laboratories (06821) rose 3.84% to HK$41.95.
[Special Authorized V] Deng Shengxing: Core inflation in the United States strengthened in August, reducing the chance of a Fed rate cut, investors should be cautious entering the market.
King News | Hang Seng closed at 17,108 on Wednesday (11th), down 125 points or 0.7%; the total market turnover was 105.7 billion yuan for the whole day. GEM Index rose for two consecutive days, but it only rose by less than 1 point today, closing at 3450. Domestic electrical utility stocks are under selling pressure. China Resources Power (00836) was downgraded by Nomura to "underperforming the market", with a stock price drop of 5.7%, performing the worst among blue chips; WuXi AppTec (02359) plans to repurchase A shares. After a sharp drop of 10.4% in H shares yesterday, it rebounded 6.8% for the whole day, performing the best among blue chips; Dow Jones closed at 408 on Wednesday (11th).
wuxi apptec (603259.SH): First repurchase of 0.5223 million shares.
On September 11, 2024, WuXi AppTec (603259.SH) announced that the company has implemented a share repurchase for the first time through centralized bidding trading. The number of repurchased shares is 0.5223 million, accounting for 0.0179% of the total share capital as of the date of this announcement. The highest repurchase price is RMB 38.67 per share, and the lowest repurchase price is RMB 37.37 per share, with a total fund amount of RMB 20,007,654.00 (excluding transaction fees).
Hong Kong stocks closed (09.11) | The Hang Seng Index fell 0.73%. Lithium mining stocks and pharmaceutical stocks rebounded strongly. Topsports (06110) plummeted 16% after issuing a profit warning.
The market is waiting for the release of the US CPI inflation data for August tonight. Hong Kong's three major stock indexes opened under pressure and fell collectively, with the Hang Seng Index and the H-share Index hitting new lows. The Hang Seng Index rebounded and turned higher in the afternoon, after falling nearly 1% earlier.
WuXi AppTec Plans 1 Billion Yuan Share Buyback in Shanghai
Top oncology conference is coming! Multiple popular anti-cancer drugs will debut, involving these A-share companies.
①The annual meeting of the European Society for Medical Oncology will be held in Barcelona, Spain in 2024; ②At the meeting, Beigene, Jiangsu Hengrui Pharmaceuticals and other listed companies will release the latest data on their oncology drugs; ③In addition, the conference will also discuss cutting-edge topics such as the impact of artificial intelligence on the diagnosis and treatment of tumors.
Abnormal movement hits directly | Stocks of innovative drugs concept are on the rise, the 2024 ESMO conference is about to be held, and institutions suggest seizing the Q3 fundamentals turning point and industry catalysis.
Innovative drug concept stocks have risen, as of press time, Beigene (06160) rose 6.97%, to HKD 124.3; Innocare-B (02162) rose 4.92%, to HKD 37.35; Innocare (09969) rose 4.91%, to HKD 5.55.
Hong Kong stocks rebounded collectively with the CRO concept stocks, WuXi AppTec announced another 1 billion yuan buyback. The Biosafety Law is still awaiting a vote in the Senate.
CRO concept stocks rebounded collectively. As of the time of writing, Pharmaron (03759) rose by 4.57%, at HKD 9.38; WuXi AppTec (02359) rose by 4.04%, at HKD 33.5; Frontage Holdings (01521) rose by 3.57%, at HKD 0.58.
[HK Stock Connect] Wuxi Apptec (02359) rose 4.66% against the market trend. The board of directors approved the third buyback plan for A shares, with a total amount of 1 billion yuan.
King Guards Financial News | Wuxi AppTec (02359) rebounds, as of the deadline, reported at 33.7 Hong Kong dollars, up 4.66%, with a turnover of 96.8891 million Hong Kong dollars. The stock fell 10.43% yesterday, closing at 32.2 Hong Kong dollars. On the news front, the board of directors approved the third repurchase of A shares in 2024, with a total amount of 1 billion RMB and a term not exceeding three months. Based on the maximum price per share of 61.02 RMB, it is estimated that the repurchased number of A shares is approximately 16.388 million shares, accounting for 0.56% of the company's total share capital. In addition, according to the latest equity disclosure information from the Hong Kong Stock Exchange
Unusual Movement | Wuxi Apptec rises more than 4% against the market and plans to repurchase 1 billion yuan of A-share shares again.
On September 11, Wuxi Apptec (02359.HK) rose over 4% against the market. As of the press release, it rose %, closing at HKD, with a turnover of ten thousand Hong Kong dollars. Market source: Futubull. On the news front, Wuxi Apptec announced that after completing the repurchase of RMB 2 billion A shares in 2024 on February 5th and May 22nd respectively, in order to further maintain the company's value and shareholder equity, it plans to continue the third time in 2024 to repurchase the company's A shares through the Shanghai Stock Exchange system by means of bidding trading, and continue to cancel all the repurchased A shares and reduce the company's registered capital.
Express News | Hong Kong Shares of WuXi AppTec Set to Open up 0.5% After Co Plans to Buy Back Shares
Wuxi Apptec (02359.HK) received a shareholding of 0.1922 million shares from FMR LLC.
According to the latest equity disclosure information from the Hong Kong Stock Exchange, on September 5, 2024, Wuxi AppTec (02359.HK) obtained FMR LLC's shareholding of 0.1922 million shares at an average price of HKD 34.9475 per share, with a total amount of approximately HKD 6.717 million. After the shareholding, the latest number of shares held by FMR LLC is 27,130,194, and the shareholding ratio has increased from 6.96% to 7.01%.
Hong Kong stock announcement | Two national-level specialized, special and new "little giant" enterprises added to circ
Wuxi AppTec (02359) plans to repurchase 1 billion yuan of A shares to further maintain the company's value and shareholder rights; Baiyunshan (00874): glyceryl trinitrate injection has passed the generic drug quality and efficacy consistency evaluation.
No Data
No Data